# Ojjaara

NDC: 81864-101
Generic name: Momelotinib
Labeler / Manufacturer: GlaxoSmithKline LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20230915

FDA application: NDA216873

## Active ingredients

- MOMELOTINIB DIHYDROCHLORIDE MONOHYDRATE: 200 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"81864-101"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=81864-101
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4a672fd1-eb7b-4aa9-9b23-845e4b5dc400